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SUMMARY 
Membrane-type 1 matrix metalloproteinase (MT1-MMP) is known to be internalized from cell 
surface, however, the fate of internalized MT1-MMP is still unknown. Here we demonstrate that at 
least a part of internalized MT1-MMP is targeted for lysosomal proteolysis. Treatment with an 
inhibitor of lysosomal proteinases chloroquine suppressed degradation of internalized MT1-MMP, 
and induced accumulation of MT1-MMP in CD63-positive lysosomes. Ectopic expression of 
CD63 accelerated degradation of MT1-MMP, which was blocked by chloroquine. MT1-MMP and 
CD63 were shown to form a complex through hemopexin-like domain of MT1-MMP and 
N-terminal region of CD63, and thus accelerated degradation of MT1-MMP was not observed with 
mutants lacking these domains. CD63 mutant lacking lysosomal targeting motif was unable to 
promote MT1-MMP degradation. These results suggest that CD63 regulates MT1-MMP by 
targeting to lysosomes. 
 




Matrix metalloproteinases (MMP) are a family of Zn2+-dependent enzymes that are essential 
for extracellular matrix (ECM) turnover in normal and pathological conditions. MMP anchored to 
plasma membrane are subgrouped into membrane-type MMP (MT-MMP) [1-5]. Of all the 
MT-MMPs, MT1-MMP is believed to be a crucial for the invasion of malignant tumors [1, 5, 6]. 
MT1-MMP activity is regulated by several distinct mechanisms. To express on cell surface, 
proMT1-MMP requires for being processed by proprotein convertases [7]. The enzymatic activity 
on the cell surface can be inhibited by the tissue inhibitors of metalloproteinases (TIMP)-2, -3, and 
-4 but not by TIMP-1. After MMP-2 activation, a part of MT1-MMP is down-regulated through 
processing by activated MMP-2 and autocatalytically [8]. Resent studies have revealed that the 
cell-surface MT1-MMP is regulated by internalization [9, 10]. However, it is largely unknown 
whether MT1-MMP is degraded at endosomes/lysosomes, or whether internalized MT1-MMP is 
recycled back to the plasma membrane. 
Tetraspanins of integral membrane proteins with four predicted transmembrane domains 
comprises a large group of ubiquitously expressed proteins that function in diverse contexts such 
as T- and B-cell activation, and cell migration and proliferation [11]. CD63 is a member of 
tetraspanins and a well-established component of the late endosomal and lysosomal membranes 
[12]. CD63 is highly expressed in primary melanoma but weaker or absent in metastatic 
melanomas [13, 14]. Ectopic expression of CD63 in melanoma cells suppresses their metastatic 
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potential in animal model system [15] . In the present study, we analyzed the fate of internalized 
MT1-MMP and the effect of CD63 on the stability of MT1-MMP and demonstrated that CD63 
plays at least in part a role in promoting lysosomal proteolysis of MT1-MMP.  
 
MATERIALS AND METHODS 
Cell Culture and Materials.  MDCK cells and HT1080 cells were maintained in Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with 5% fetal bovine serum (FBS). HeLa cells 
and 293-EBNA cells (Invitrogen) were cultured in DMEM supplemented with 10% FBS. MMP 
inhibitor, BB94 was prepared as described previously [16]. Antibodies used were: anti-actin and 
anti-FLAG M2 mouse monoclonal antibodies (Sigma-Aldrich); an anti-GFP rabbit polyclonal 
antibody (Santa Cruz Biotechnology); anti-CD63 mouse monoclonal and anti-MT1-MMP rabbit 
polyclonal antibodies (Chemicon); horseradish peroxidase (HRP) conjugated secondary antibodies 
and streptavidin (Amersham Pharmacia Biothech). 
Expression Plasmids.  pSG5-MMP-2, FLAG epitope tagged-MT1-MMP (MT1F), the 
catalytic domain-deleted mutant (∆Cat), the hemopexin-like domain-deleted mutant (∆Pex) and the 
cytoplasmic tail-deleted mutant (∆CP) of MT1F were constructed as described previously [10]. 
pRK-GFP was provided from Dr. K.M. Yamada (National Institutes of Health, Bethesda, MD). The 
puromycin resistance plasmid pHA262pur was kindly provided by Dr. Hein te Riele (Netherlands 
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Cancer Institute, Amsterdam, The Netherlands). A cDNA enconding CD63 (GenBank accession 
number BC002349) was obtained by RT-PCR with human placenta cDNA and was cloned into the 
pRK-GFP expression vector. pRK-GFP-CD63 was used as a template for PCR-based modification 
to generate the deletion mutants for the small extracellular loop (Met1-Ser51)-deleted mutant 
(∆SEL), the large extracxellular loop (Val106-Lys186)-deleted mutant (∆LEL), the cytoplasmic 
domain-deleted mutant (∆C12; Leu227-Met238) of GFP-CD63. 
Transfection.  Transient transfections were performed by either calcium phosphate methods or 
using Trans IT-LT1 (PanVera) according to the manufacture’s instructions. To obtain MDCK 
cells stably expressing GFP-CD63, MDCK cells were co-transfected with pRK-GFP-CD63 and 
pHA262pur plasmids and selected in medium containing puromycin. 
Immunoprecipitations and Immunoblottings.  The cells were washed with ice-cold 
phosphate buffered saline (PBS), homogenized in a buffer containing 50 mM Tris-HCl (pH 7.5), 
150 mM NaCl, 1 mM EGTA, 1 mM PMSF, 1 mM Na3VO4, 1 mM NaF, 1% TritonX-100. The 
cell lysates were used for immunoprecipitation with anti-FLAG-M2 antibody. The 
immunoprecipitates were subjected to immunoblotting using indicated antibodies. 
Gelatin Zymography.  Gelatin zymography was performed with SDS-polyacrylamide gel 
containing 0.1% gelatin as described previously [3]. Gelatinolytic activity was visualized as a 
negative staining with Coomassie Brilliant Blue. 
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Cell-Surface Biotinylation.  Transfected HeLa cells were washed with ice-cold PBS, 
incubated with 0.5 mg/ml sulfo-NHS-biotin (Pierce) in PBS at 4°C for 30 min, and then further 
incubated with 25 mM lysine. The cells were cultured for 3 h in complete medium with or 
without chloroquine (116 µM), homogenized and immunoprecipitated with anti-FLAG M2 
antibody. The immunoprecipitates were analyzed by immunoblotting using streptavidine-HRP or 
anti-FLAG antibody. 
Immunofluorescence Staining.  For cell-surface staining, cells were incubated for 30 min at 
4°C with anti-FLAG M2 antibody. After washing, cells were incubated in complete media with 
BB94 (1 µM) at 37°C for indicated period. The cells were fixed with 4% paraformaldehyde for 
15 min and permeabilized with (permeabilized) or without (non-permeabilized) 4% 
paraformaldehyde/0.5% Triton X-100 for 5min, and then visualized with Cy3- or 
Alexa488-conjugated goat anti-mouse IgG (Molecular Probes) using confocal laser microscopy 
(Carl Zeiss). For CD63 staining, cells were fixed with 4% paraformaldehyde for 20 min, treated 
for 30 min with 0.27% NH4Cl/0.38% glycin in PBS, and permeabilized for 30 min with 0.05% 
saponin in PBS. 
 
RESULTS 
Internalized MT1-MMP is localized at CD63-positive lysosomes.  Internalization of 
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FLAG-tagged MT1-MMP (MT1F) in HeLa cells was examined by fluorescence immunostaining. 
MT1F was localized at the periphery of permeabilized and non- permeabilized cells at 0 time (Fig. 
1A). While the signal became weaker at 30 min and undetectable at 3 h after labeling in 
non-permeabilized cells, MT1F was detected in cytoplasm as dot-like spots at 3 h after labeling 
in permeabilized cells. Next, to examine whether MT1F is subjected to lysosomal proteolysis, the 
effect of a lysosomal proteases inhibitor chloroquine was studied (Fig. 1B). MT1F was localized 
mainly in the cytoplasm in un-treated cells, however, chloroquine treatment induced 
accumulation of MT1F and co-localization with CD63 as dot-like spots. Suppression of 
degradation of surface-labeled MT1-MMP by chloroquine was confirmed by western blotting 
(Fig. 1C). These results indicate that a part of MT1-MMP internalized from cell surface is 
transported and degraded at CD63-positive lysosomes.  
CD63 down-regulates MT1-MMP.  The effect of CD63 on MT1-MMP expression was 
examined. Co-expression of MT1F with MMP-2 induced processing of MMP-2 from 68-kDa 
latent form to 64-kDa intermediate and 62-kDa active forms as shown by gelatin zymography 
(Fig. 2A). Transfection of CD63 plasmid down-regulated MMP-2 processing by dose dependent 
manner. Expression level of MT1-MMP was drastically reduced by CD63 expression as 
demonstrated by western blotting (Fig. 2B), which was clearly restored by the treatment of cells 
with chloroquine. MMP inhibitor BB94 had no effect. These results suggest that CD63 
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expression reduces the level of cell-surface MT1-MMP and promotes its lysosomal proteolysis. 
To analyze the mechanism of CD63-dependent proteolysis of MT1-MMP, cell-surface 
MT1-MMP on CD63-expressing cells was pulse-labeled with the antibody, and the 
internalization of MT1-MMP was monitored. Internalized MT1-MMP accumulated and 
co-localized with CD63 in lysosomes (Fig. 2C). These results may suggest that reduction of cell 
surface MT1-MMP by CD63 expression is due to promoted internalization and degradation at 
lysosome.  
Interaction between CD63 and MT1-MMP.  To analyze the interaction between MT1-MMP 
and CD63, immunoprecipitation was performed. As shown in Fig. 3B, CD63 was co-precipitated 
with MT1F. CD63 mutants lacking the C-terminal cytoplasmic tail or the C-terminal large 
extracellular loop (LEL) (∆LEL) was co-precipitated with MT1-MMP, while mutants lacking the 
N-terminal small extracellular loop (SEL) (∆SEL) of CD63 failed. In addition, although WT-CD63 
reduced the level of MT1-MMP, the ∆C12, ∆SEL, and ∆LEL mutants of CD63 did not. The 
MT1-MMP mutant lacking hemopexin-like domain (∆Pex) was not co-precipitated with CD63, 
whereas other mutants of MT1-MMP did (Fig. 3D). Consequently, co-expression of CD63 reduced 
the level of MT1F but not that of MT1F∆Pex (Fig. 3E). These results suggest that N-terminus of 
CD63 and hemopexin-like domain of MT1-MMP are necessary for the association, but not 
sufficient to promote lysosomal proteolysis of MT1-MMP. 
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Role of cytoplasmic tails of MT1-MMP and CD63.  The C-terminal cytoplasmic tail of CD63 
contains the lysosomal targeting motif GYEYM, which interacts with the µ2 subunit of adaptor 
protein (AP)-2 adaptor and the µ3 subunit of AP-3 [17, 18]. In fact, the deficiency of AP-3 results 
in increased cell-surface expression of CD63 due to lack of its lysosomal trafficking [17]. The role 
of CD63 C-terminal cytoplasmic tail in promotion of MT1-MMP lysosomal proteolysis was 
studied. MT1F was localized at cell periphery in the cells expressing MT1F alone, and cell-surface 
staining of MT1F was significantly reduced in cells co-expressing GFP-CD63 (Fig. 4A). CD63 
accumulated at lysosomes, however, CD63∆C12 was mainly distributed in cytoplasm and cell 
periphery. Cell-surface localization of MT1F was not significantly affected by CD63∆C12 
expression. Figure 4B showed the relative levels of cell-surface MT1-MMP in cells co-expressing 
CD63 or their mutants. CD63 expression markedly reduced cell-surface expression of MT1-MMP, 
but MT1F∆Pex was not significantly reduced by CD63 expression. Cell-surface expression of 
MT1F∆CP was faintly down-regulated by CD63 expression. In addition, CD63∆C12 expression 
did not attenuate cell-surface expression of MT1F. Hence, CD63 expression apparently 
down-regulated MMP-2 activation mediated by MT1F, but that by MT1F∆CP was affected only 





In the present study we demonstrated for the first time that a part of MT1-MMP internalized 
from cell surface is transported to CD63-positive lysosomes and degraded there. Ectopic 
expression of CD63 promoted lysosomal proteolysis of MT1-MMP (Fig. 2B). The direct 
interaction between MT1-MMP and CD63 was shown to be mediated through the 
hemopexin-like domain of MT1-MMP and N-terminal region of CD63 (Fig. 3). Thus, 
MT1-MMP level was not altered by the expression of CD63∆SEL, and MT1F∆Pex by CD63 (Fig. 
4). Targeting of the complex to lysosome is mediated by lysosomal targeting motif of CD63 
(GYEYM) which is located at the C-terminal tail, and thus CD63∆C12 was unable to stimulate 
lysosomal proteolysis of MT1-MMP (Fig. 3B). 
The importance of cytoplsmic tail of MT1-MMP for the internalization from cell surfac was 
demonstrated by Uekita et al. [10] and in this study (Fig. 4). The cytoplasmic tails of MT1-MMP 
and CD63 interact with the µ2 subunit of AP-2 adaptor. Thus, the interaction between MT1-MMP 
and CD63 may promote their internalization. The facts that expression of CD63 is ubiquitous and 
internalized MT1-MMP is co-localized with endogenous CD63 at lysosomes suggest that CD63 
is one of regulators of MT1-MMP. However, the mechanism of CD63-mediated internalization of 
MT1-MMP still remained examined. Further study is required to clarify whether the association 
of CD63/MT1-MMP complex with integrin α3β1, CD81, phosphatidylinositol 4 kinase [19], and 
 11
other proteins such as CD44 [20] and claudins [21] can regulate MT1-MMP enzymatic activity 
and dynamic turnover of MT1-MMP at cell periphery.  
In conclusion, we have shown that CD63 is involved in the internalization of MT1-MMP from 
cell-surface, lysosomal targeting and proteolysis of MT1-MMP. Understanding the mechanism by 
which MT1-MMP is internalized from cell surface, transported to lysosomes, and presumably 
recycled back to plasma membrane might provide a step to regulate MT1-MMP activity which is 
closely associated with the invasiveness and metastasis of malignant tumor cells. 
 
ACKNOWLEDGMENTS 
This work was supported by a Grant-in-Aid for Science Research on Priority Areas from the 
Ministry of Education, Culture, Sports, Science, and Technology of Japan (to T.T and H.S). 
 
REFERENCE 
[1] H. Sato, T. Takino, Y. Okada, J. Cao, A. Shinagawa, E. Yamamoto, and M. Seiki, A matrix 
metalloproteinase expressed on the surface of invasive tumour cells, Nature 370 (1994) 61-65. 
[2] T. Takino, H. Sato, E. Yamamoto, and M. Seiki, Cloning of a human gene potentially encoding 
a novel matrix metalloproteinase having a C-terminal transmembrane domain, Gene 155 (1995) 
293-298. 
 12
[3] T. Takino, H. Sato, A. Shinagawa, and M. Seiki, Identification of the second membrane-type 
matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs 
form a unique membrane-type subclass in the MMP family, J Biol Chem 270 (1995) 23013-23020. 
[4] D. Pei, Identification and characterization of the fifth membrane-type matrix metalloproteinase 
MT5-MMP, J Biol Chem 274 (1999) 8925-8932. 
[5] M. Seiki, Membrane-type matrix metalloproteinases, Apmis 107 (1999) 137-143. 
[6] Y. Tsunezuka, H. Kinoh, T. Takino, Y. Watanabe, Y. Okada, A. Shinagawa, H. Sato, and M. 
Seiki, Expression of membrane-type matrix metalloproteinase 1 (MT1-MMP) in tumor cells 
enhances pulmonary metastasis in an experimental metastasis assay, Cancer Res 56 (1996) 
5678-5683. 
[7] I. Yana, and S. J. Weiss, Regulation of membrane type-1 matrix metalloproteinase activation by 
proprotein convertases, Mol Biol Cell 11 (2000) 2387-2401. 
[8] K. Lehti, J. Lohi, H. Valtanen, and J. Keski-Oja, Proteolytic processing of membrane-type-1 
matrix metalloproteinase is associated with gelatinase A activation at the cell surface, Biochem J 
334 ( Pt 2) (1998) 345-353. 
[9] A. Jiang, K. Lehti, X. Wang, S. J. Weiss, J. Keski-Oja, and D. Pei, Regulation of 
membrane-type matrix metalloproteinase 1 activity by dynamin-mediated endocytosis, Proc Natl 
Acad Sci U S A 98 (2001) 13693-13698. 
 13
[10] T. Uekita, Y. Itoh, I. Yana, H. Ohno, and M. Seiki, Cytoplasmic tail-dependent internalization 
of membrane-type 1 matrix metalloproteinase is important for its invasion-promoting activity, J 
Cell Biol 155 (2001) 1345-1356. 
[11] F. Berditchevski, Complexes of tetraspanins with integrins: more than meets the eye, J Cell 
Sci 114 (2001) 4143-4151. 
[12] M. Fukuda, Lysosomal membrane glycoproteins. Structure, biosynthesis, and intracellular 
trafficking, J Biol Chem 266 (1991) 21327-21330. 
[13] H. Hotta, A. H. Ross, K. Huebner, M. Isobe, S. Wendeborn, M. V. Chao, R. P. Ricciardi, Y. 
Tsujimoto, C. M. Croce, and H. Koprowski, Molecular cloning and characterization of an antigen 
associated with early stages of melanoma tumor progression, Cancer Res 48 (1988) 2955-2962. 
[14] M. Kondoh, M. Ueda, M. Ichihashi, and Y. Mishima, Decreased expression of human 
melanoma-associated antigen ME491 along the progression of melanoma pre-canceroses to 
invasive and metastatic melanomas, Melanoma Res 3 (1993) 241-245. 
[15] K. J. Radford, J. Mallesch, and P. Hersey, Suppression of human melanoma cell growth and 
metastasis by the melanoma-associated antigen CD63 (ME491), Int J Cancer 62 (1995) 631-635. 
[16] T. Kinoshita, H. Sato, A. Okada, E. Ohuchi, K. Imai, Y. Okada, and M. Seiki, TIMP-2 
promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized 
on agarose beads, J Biol Chem 273 (1998) 16098-16103. 
 14
[17] E. C. Dell'Angelica, V. Shotelersuk, R. C. Aguilar, W. A. Gahl, and J. S. Bonifacino, Altered 
trafficking of lysosomal proteins in Hermansky-Pudlak syndrome due to mutations in the beta 3A 
subunit of the AP-3 adaptor, Mol Cell 3 (1999) 11-21. 
[18] T. Kobayashi, U. M. Vischer, C. Rosnoblet, C. Lebrand, M. Lindsay, R. G. Parton, E. K. 
Kruithof, and J. Gruenberg, The tetraspanin CD63/lamp3 cycles between endocytic and secretory 
compartments in human endothelial cells, Mol Biol Cell 11 (2000) 1829-1843. 
[19] F. Berditchevski, K. F. Tolias, K. Wong, C. L. Carpenter, and M. E. Hemler, A novel link 
between integrins, transmembrane-4 superfamily proteins (CD63 and CD81), and 
phosphatidylinositol 4-kinase, J Biol Chem 272 (1997) 2595-2598. 
[20] H. Mori, T. Tomari, N. Koshikawa, M. Kajita, Y. Itoh, H. Sato, H. Tojo, I. Yana, and M. Seiki, 
CD44 directs membrane-type 1 matrix metalloproteinase to lamellipodia by associating with its 
hemopexin-like domain, Embo J 21 (2002) 3949-3959. 
[21] H. Miyamori, T. Takino, Y. Kobayashi, H. Tokai, Y. Itoh, M. Seiki, and H. Sato, Claudin 
promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix 
metalloproteinases, J Biol Chem 276 (2001) 28204-28211. 
 
FIGURE LEGENDS 
FIG. 1. Localization of internalized MT1-MMP. (A) HeLa cells were transfected with MT1F, and 
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incubated with anti-FLAG antibody for 30 min at 4 °C. After washing, the cells were cultured in 
complete media for 0, 30 min, or 3 h, and then performed immunofluorescence staining under 
either permeabilized (+TX100) or non-permeabilized (-TX100) conditions as described in 
Materials and Methods. (B) HeLa cells were transfected with MT1F, and cultured in the presence 
(+) or absence (-) of chloroquine (CHQ; 58 µM) for 6h. The cells were fixed under permeabilized 
condition, and then stained with anti-CD63 and anti-MT1-MMP antibodies. Bar, 20 µm. (C) 
Cell-surface biotinylation and immunoprecipitation were carried out as described in Materials and 
Methods. Cell-surface MT1F was detected by streptavidine-HRP (Blot: SA-HRP), and total MT1F 
was by anti-FLAG antibody (Blot: FLAG). The whole-cell lysates (WCL) were immunoblotted 
with anti-actin (Blot: Actin) antibody. 
 
FIG. 2. CD63 down-regulates MT1-MMP. (A) 293-EBNA cells were co-transfected with MMP-2, 
MT1F and 50 ng, 200 ng, or 1 µg of GFP-CD63 plasmids. The conditioned media were analyzed 
by gelatin zymography. (B) 293-EBNA cells were co-transfected with MT1F and either GFP or 
GFP-CD63 plasmids, and treated with DMSO, BB94, chroloquine (CHQ) overnight. The cells 
were homogenized, and immunoblotted with anti-FLAG (Blot: FLAG) or anti-GFP (Blot: GFP) 
antibody. (C) MDCK cells stably expressing GFP-CD63 were transiently transfected with MT1F, 
incubated with anti-FLAG antibody conjugated with Alexa546 for 30 min, and cultured further 
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30 min or 6 h in the presence of BB94 with or without chloroquine (CHQ). The cells were fixed 
with 4% paraformaldehyde. Bar, 20 µm. 
 
FIG. 3. Interaction between CD63 and MT1-MMP. (A) CD63 composes with four transmembrane 
domains (TM1 to TM4), and two extracellular loop, SEL and LEL. 293-EBNA cells were 
co-transfected with MT1F and GFP-CD63 mutants (B) or co-transfected with GFP-CD63∆C12 
and MT1-MMP mutants (D). The cell lysates were precipitated with anti-FLAG antibody (IP: 
FLAG), and analyzed by immunoblotting with anti-GFP antibody (Blot: GFP). The WCL were 
immunoblotted with anti–FLAG (Blot: FLAG) or anti-GFP (Blot: GFP) antibody. (C) a schematic 
representation of MT1-MMP mutants. SP, signal peptide; Pro, propeptide; Cat, catalytic domain; H, 
hinge region; Pex, hemopexin-like domain; TM, transmembrane domain; CP, cytoplasmic domain; 
FLAG, FLAG epitope. (E), HeLa cells were co-transfected with MT1F or MT1F∆Pex and GFP or 
GFP-CD63 plasmids, and cultured in the presence of BB94 (1 µM) for 12 h. The cells were 
homogenized, and immunoblotted with anti-FLAG (Blot: FLAG) antibody. 
 
FIG. 4. Role of cytoplasmic tails of MT1-MMP and CD63. (A) HeLa cells were co-transfected 
with MT1F or MT1F∆CP and either GFP, GFP-CD63 or GFP-CD63∆C12 plasmids. The 
cell-surface MT1-MMP were labeled with anti-FLAG M2 antibody for 30 min at 4°C, and the 
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immunofluorescence staining was performed under non-permeabilized condition. Bar, 20 µm. (B) 
the values of fluorescence intensity per cell were determined by immunofluorescence staining. 
Data was collected from at least 30 cells from three independent experiments. Asterisk, P < 0.0001. 
Error bars indicate SD. (C) HeLa cells were co-transfected with MT1F or MT1F∆CP, MMP-2, and 
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